Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 58 entries
View as:

Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2

Phase: N/A Priority: Normal
NCT ID: NCT01685827 Org: User:
Start: 10/31/12 End: 04/26/17 Due: 04/26/18

Efficacy and Safety of Fexinidazole in Children at Least 6 Years Old and Weighing Over 20 kg With Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open Study, plug-in to the Pivotal Study

Phase: N/A Priority: Normal
NCT ID: NCT02184689 Org: User:
Start: 05/03/14 End: 06/27/17 Due: 06/27/18

Study to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease

Phase: N/A Priority: Normal
NCT ID: NCT02498782 Org: User:
Start: 07/31/14 End: 02/29/16 Due: 02/28/17

Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

Phase: N/A Priority: Normal
NCT ID: NCT00982904 Org: User:
Start: 09/30/09 End: 10/31/10 Due: 10/31/11

Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

Phase: N/A Priority: Normal
NCT ID: NCT00696969 Org: User:
Start: 06/30/08 End: 01/31/10 Due: 01/31/11

Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan

Phase: N/A Priority: Normal
NCT ID: NCT03086226 Org: User:
Start: 05/09/17 End: 03/07/22 Due: 03/07/23

Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions

Phase: N/A Priority: Normal
NCT ID: NCT01340157 Org: User:
Start: 02/28/11 End: 04/30/11 Due: 04/30/12

ADME Study of Acoziborole in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04270981 Org: User:
Start: 02/05/20 End: 07/08/20 Due: 07/08/21

Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Phase: N/A Priority: Normal
NCT ID: NCT04515186 Org: User:
Start: 01/26/21 End: 02/27/24 Due: 02/27/25

Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

Phase: N/A Priority: Normal
NCT ID: NCT02348177 Org: User:
Start: 01/31/13 End: 12/31/16 Due: 12/31/17

Emodepside Phase II Trial for Treatment of Onchocerciasis

Phase: N/A Priority: Normal
NCT ID: NCT05180461 Org: User:
Start: 08/30/21 End: 10/02/26 Due: 10/02/27

Short Course Regimens for Treatment of PKDL (Sudan)

Phase: N/A Priority: Normal
NCT ID: NCT03399955 Org: User:
Start: 05/09/18 End: 05/01/22 Due: 05/01/23

Eumycetoma Long-term Post-Treatment Follow-Up Study

Phase: N/A Priority: Normal
NCT ID: NCT06514183 Org: User:
Start: 01/26/23 End: 06/26/23 Due: 06/26/24

Strategic Transformation of the Market of HCV Treatments

Phase: N/A Priority: Normal
NCT ID: NCT02961426 Org: User:
Start: 09/30/16 End: 03/31/24 Due: 03/31/25

LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study

Phase: N/A Priority: Normal
NCT ID: NCT05957978 Org: User:
Start: 03/29/24 End: 10/03/25 Due: 10/03/26

Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food

Phase: N/A Priority: Normal
NCT ID: NCT01483170 Org: User:
Start: 09/30/11 End: 02/29/12 Due: 02/28/13

BENDITA BEnznidazole New Doses Improved Treatment and Associations

Phase: N/A Priority: Normal
NCT ID: NCT03378661 Org: User:
Start: 11/30/16 End: 07/27/18 Due: 07/27/19

Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL

Phase: N/A Priority: Normal
NCT ID: NCT00832208 Org: User:
Start: 04/30/09 End: 03/31/11 Due: 03/31/12

Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense

Phase: N/A Priority: Normal
NCT ID: NCT03087955 Org: User:
Start: 10/11/16 End: 08/28/20 Due: 08/28/21

Proof-of-Concept Study of E1224 to Treat Adult Patients With Chagas Disease

Phase: N/A Priority: Normal
NCT ID: NCT01489228 Org: User:
Start: 06/30/11 End: 12/31/13 Due: 12/31/14

Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside

Phase: N/A Priority: Normal
NCT ID: NCT03383614 Org: User:
Start: 11/14/17 End: 10/15/18 Due: 10/15/19

Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease

Phase: N/A Priority: Normal
NCT ID: NCT01549236 Org: User:
Start: 05/31/11 End: 10/31/12 Due: 10/31/13

Efficacy and Safety of Fexinidazole in Patients With Stage 1 or Early Stage 2 Human African Trypanosomiasis (HAT) Due to T.b. Gambiense: a Prospective, Multicentre, Open-label Cohort Study, plug-in to the Pivotal Study

Phase: N/A Priority: Normal
NCT ID: NCT02169557 Org: User:
Start: 04/30/14 End: 04/25/17 Due: 04/25/18

Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease

Phase: N/A Priority: Normal
NCT ID: NCT03587766 Org: User:
Start: 11/13/17 End: 08/28/19 Due: 08/28/20

Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage

Phase: N/A Priority: Normal
NCT ID: NCT03025789 Org: User:
Start: 11/10/16 End: 02/01/21 Due: 02/01/22